Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2022 Mar 19;32(6):1418–1426. doi: 10.1016/j.numecd.2022.03.014

Table 2:

Parameter estimates from multivariable linear regression models associating total DASH- score with glucose homeostasis traits, in the whole MILES sample and stratified by dysglycemia and weight status

Glycemic category Weight category
All participants
(N=339)
Normoglycemic
(N=174)
Dysglycemic
(N=159)
Normal weight
(N= 101)
Overweight/obese
(N=232)
β (SE) P β (SE) P β (SE) P β (SE) P β (SE) P
Fasting glucose 0.036 (0.012) .005 0.026 (0.013) .046 −0.019 (0.014) .183 −0.023 (0.020) .251 −0.041 (0.016) .098
Fasting insulin −0.01 (0.01) .287 0.005 (0.150) .729 −0.014 (0.013) .296 −0.011 (0.019) .577 −0.006 (0.012) .647
Fasting C-peptide −0.018 (0.01) 0.943 0.0003 (0.015) .982 −0.020 (0.013) .106 −0.009 (0.018) .601 −0.017 (0.013) .180
Insulin sensitivity 0.022 (0.011) .042 0.001 (0.014) .918 0.024 (0.013) .068 0.017 (0.019) .377 0.018 (0.012) .149
Insulin secretion 0.0003 (0.012) .978 0.013 (0.017) .458 −0.011 (0.017) .53 −0.002 (0.022) .941 0.007 (0.015) .659
Disposition index 0.026 (0.013) .038 0.021 (0.172) .172 0.013 (0.014) .374 0.020 (0.022) .359 0.028 (0.016) .074

Note: All models control for age, sex, race, body mass index (BMI), education level, income, physical activity and energy intake. Significant results (P<.05) in bold.